Literature DB >> 32701834

Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury.

Marcela Davoli-Ferreira1,2, Kalil A de Lima1,2, Miriam M Fonseca1, Rafaela M Guimarães1, Francisco I Gomes1, Maria C Cavallini1,2, Andreza U Quadros1, Ricardo Kusuda1, Fernando Q Cunha1, Jose C Alves-Filho1, Thiago M Cunha1.   

Abstract

The inflammatory/immune response at the site of peripheral nerve injury participates in the pathophysiology of neuropathic pain. Nevertheless, little is known about the local regulatory mechanisms underlying peripheral nerve injury that counteracts the development of pain. Here, we investigated the contribution of regulatory T (Treg) cells to the development of neuropathic pain by using a partial sciatic nerve ligation model in mice. We showed that Treg cells infiltrate and proliferate in the site of peripheral nerve injury. Local Treg cells suppressed the development of neuropathic pain mainly through the inhibition of the CD4 Th1 response. Treg cells also indirectly reduced neuronal damage and neuroinflammation at the level of the sensory ganglia. Finally, we identified IL-10 signaling as an intrinsic mechanism by which Treg cells counteract neuropathic pain development. These results revealed Treg cells as important inhibitory modulators of the immune response at the site of peripheral nerve injury that restrains the development of neuropathic pain. In conclusion, the boosting of Treg cell function/activity might be explored as a possible interventional approach to reduce neuropathic pain development after peripheral nerve damage.

Entities:  

Mesh:

Year:  2020        PMID: 32701834     DOI: 10.1097/j.pain.0000000000001879

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  16 in total

1.  Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.

Authors:  Mihály Balogh; Jelena M Janjic; Andrew J Shepherd
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

2.  Low-dose interleukin-2 reverses chronic migraine-related sensitizations through peripheral interleukin-10 and transforming growth factor beta-1 signaling.

Authors:  Zhaohua Guo; Jintao Zhang; Xuemei Liu; Jacqueline Unsinger; Richard S Hotchkiss; Yu-Qing Cao
Journal:  Neurobiol Pain       Date:  2022-06-13

Review 3.  Potential Neuroimmune Interaction in Chronic Pain: A Review on Immune Cells in Peripheral and Central Sensitization.

Authors:  Jia-Xuan Yang; Hong-Fei Wang; Ji-Zhun Chen; Han-Yu Li; Ji-Chen Hu; An-An Yu; Jun-Jun Wen; Si-Jia Chen; Wei-Dong Lai; Song Wang; Yan Jin; Jie Yu
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-04

Review 4.  TREGking From Gut to Brain: The Control of Regulatory T Cells Along the Gut-Brain Axis.

Authors:  Juli Choi; Bo-Ram Kim; Begum Akuzum; Leechung Chang; June-Yong Lee; Ho-Keun Kwon
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 5.  Regenerative Role of T Cells in Nerve Repair and Functional Recovery.

Authors:  Xiaoxuan Tang; Qiaoyuan Li; Tingting Huang; Han Zhang; Xiaoli Chen; Jue Ling; Yumin Yang
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

6.  Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10.

Authors:  Mariaconcetta Durante; Silvia Squillace; Filomena Lauro; Luigino Antonio Giancotti; Elisabetta Coppi; Federica Cherchi; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Grant Kolar; Carrie Wahlman; Adeleye Opejin; Cuiying Xiao; Marc L Reitman; Dilip K Tosh; Daniel Hawiger; Kenneth A Jacobson; Daniela Salvemini
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

Review 7.  T Cells as Guardians of Pain Resolution.

Authors:  Annemieke Kavelaars; Cobi J Heijnen
Journal:  Trends Mol Med       Date:  2021-01-08       Impact factor: 11.951

8.  Sex differences in neuro(auto)immunity and chronic sciatic nerve pain.

Authors:  Katja Linher-Melville; Anita Shah; Gurmit Singh
Journal:  Biol Sex Differ       Date:  2020-11-12       Impact factor: 5.027

9.  Immune-mediated vincristine-induced neuropathy: Unlocking therapies.

Authors:  Masha G Savelieff; Eva L Feldman
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

10.  Identification of DNA methylation associated enrichment pathways in adults with non-specific chronic low back pain.

Authors:  Edwin N Aroke; Demario S Overstreet; Terence M Penn; David K Crossman; Pamela Jackson; Trygve O Tollefsbol; Tammie L Quinn; Nengjun Yi; Burel R Goodin
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.